Edition:
India

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
20 Sep 2019
Change (% chg)

$0.00 (+0.03%)
Prev Close
$0.95
Open
$0.95
Day's High
$0.95
Day's Low
$0.90
Volume
45,500
Avg. Vol
21,439
52-wk High
$2.52
52-wk Low
$0.82

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 September 21 Sep 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-19 1 -0.14 -0.14 -0.14 -0.11
Year Ending Sep-19 1 -0.61 -0.61 -0.61 -0.54
Year Ending Sep-20 1 -0.38 -0.38 -0.38 1.72

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-19 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 -0.20 -0.20 0.00 -0.00
Quarter Ending Dec-18 -0.21 -0.22 0.01 -4.76
Quarter Ending Jun-18 -0.32 -0.19 0.13 -40.62

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 0.00 -- -- -- --
Earnings (per share)
Quarter Ending Sep-19 -0.14 -0.14 -- -0.11 -0.11
Year Ending Sep-19 -0.61 -0.61 -- -0.56 -0.54
Year Ending Sep-20 -0.38 -0.38 -- 0.06 1.72

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 -- -- -- --
Earnings
Quarter Ending Sep-19 0 0 -- --
Year Ending Sep-19 0 0 -- --
Year Ending Sep-20 0 0 -- --